Quality of life and survival prediction in terminal cancer patients: A multicenter study

Cancer

Volumn 101, Issue 5, 2004, Pages 1090-1098

  Vigano, Antonio ^a,e   Donaldson, Nora ^b   Higginson, Irene J ^b   Bruera, Eduardo ^c   Mahmud, Salaheddin ^a   Suarez Almazor, Maria ^d  

^a MCGILL UNIVERSITY   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Multicenter study; Palliative care; Quality of life; Survival prediction; Symptom assessment; Terminal cancer

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BREAST TUMOR; CACHEXIA; CANCER PALLIATIVE THERAPY; CANCER PATIENT; COHORT ANALYSIS; DIGESTIVE SYSTEM TUMOR; DISTRESS SYNDROME; DYSPNEA; FEMALE; HUMAN; LIVER METASTASIS; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RELIGION; STATISTICAL ANALYSIS; SURVIVAL; TERMINALLY ILL PATIENT; UROGENITAL TRACT TUMOR; VOMITING;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE; TERMINALLY ILL;

EID: 4143104743     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20472     Document Type: Article

References (60)

1. Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997;33: 1025-1030.
2. Loprinzi CL, Laurie JA, Wieand HS, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol. 1994;12:601-607.
3. Sloan JA, Loprinzi CL, Laurine JA, et al. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol. 2001;19:3539-3546.
4. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002;20:2514-2519.
5. Coates AS, Gebski V, Bishop JF, et al. Improving the quality of life in advanced breast cancer. A comparison of continuous and intermittent strategies. N Engl J Med. 1987;317: 1490-1495.
6. Coates AS, Byrne M, Bishop JF, et al. Intermittent versus continuous chemotherapy for breast cancer [letter]. N Engl J Med. 1988;318:1468.
7. Coates AS, Gebski V, Signorini D, et al. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. Australian-New Zealand Breast Cancer Trials Group. J Clin Oncol. 1992;10:1833-1838.
8. Butow PN, Coates AS, Dunn SM. Psychosocial predictor of survival: metastatic breast cancer. Ann Oncol. 2000;11:469-474.
9. Shimozuma K, Sonoo H, Ichihara K, et al. The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. Surg Today. 2000;30: 255-261.
10. Coates AS, Hurny C, Peterson HF, et al. Quality-of-life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol. 2000;18:3768-3774.
11. Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut. 2001;49:227-230.
12. Earlam S, Glover C, Fordy C, et al. Relation between tumor size, quality of life and survival in patients with colorectal liver metastases. J Clin Oncol. 1996:14:171-175.
13. Coates AS, Thomson D, McLeod GR, et al. Prognostic value of quality of life score in trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer. 1993;29A:1731-1734.
14. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol. 1999;17: 2256-2263.
15. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease: the importance of patients' subjective experience of disease and psychosocial well-being. Radiol Oncol. 1989;15: 235-242.
16. Ruckdeschel JC, Piantadosi S, The Lung Cancer Study Group. Quality of life assessments in lung surgery for brochogenic carcinoma. Theor Surg. 1991;6:201-205.
17. Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer. 1991;67:3131-3135.
18. Buccheri GF, Ferrigno D, Tamburini M, Brunelli C. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer. 1995;12:45-58.
19. Herndon JE II, Fleishman S, Kornblith AB, et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999;85:333-340.
20. Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: an important prognostic factor. Lung Cancer. 2001;31:233-240.
21. Tamburini M, Brunelli C, Rosso S, Ventafridda V. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage. 1996;1:32-41.
22. Maltoni M, Pirovano M, Nanni O, et al. Prognostic factors in terminal cancer patients. Eur J Palliat Care. 1996;3:122-125.
23. Viganò A, Dorgan M, Bruera E, Buckingam J, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med. 2000;14:363-374.
24. Cassileth BR, Lusk EJ, Miller DS, et al. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985;312:1551-1555.
25. Cassileth BR, Walsh WP, Lusk EJ. Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol. 1988;6:1753-1759.
26. Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG. Quality of life of cancer patients with different prognoses. Qual Life Res. 1994;3:143-154.
27. Ringdal GI, Gotestam KG, Kaasa S, et al. Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer. 1996;73:1594-1599.
28. Ringdal GI, Ringdal K. A follow-up study of the quality of life in cancer patients with different prognoses. Qual Life Res. 2000;9:65-73.
29. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer's Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 1990;62:695-699.
30. Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patient receiving chemotherapy. Qual Life Res. 1997; 6:151-158.
31. Chang VT, Thaler H, Polyak TA, et al. Quality of life and survival. Cancer. 1998;83:173-179.
32. Laupacis A, Wells G, Richardson WS, et al. Users' guides to medical literature, V. How to use an article about prognosis. JAMA. 1994;272:234-237.
33. Roud PC. Psychosocial variables associated with the exceptional survival of patients with advanced malignant disease. Int J Psychiatr Med. 1986/1987;16:113-122.
34. Watson M, Haviland JS, Greer S, et al. Influence of psychological response on survival in breast cancer; a population cohort study. Lancet. 1999;354:1331-1336.
35. Hodgson C, Higginson IJ, McDonnell M, Butters E. Family anxiety in advanced cancer: a multicentre prospective study in Ireland. Br J Cancer. 1997;76:1211-1214.
36. Edmonds P, Higginson I, Altmann D, Sen-Gupta G, McDonnell M. Is the presence of dyspnea a risk factor for morbidity in cancer patients? J Pain Symptom Manage. 2000;19:15-22.
37. Higginson IJ, Costantini M. Communication in end-of-life cancer care: a comparison of team assessments in three European countries. J Clin Oncol. 2002;20:3674-3682.
38. Viganò A, Bruera E, Suarez-Almazor ME. Terminal cancer syndrome: myth or reality. J Palliat Care. 1999;15:32-39.
39. Karfnosky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949:199-205.
40. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-376.
41. Higginson I, McCarthy MA. comparison of two measures of quality of life: their sensitivity and validity for patients with advanced cancer. Palliat Med. 1994;8:282-290.
42. Higginson I, McCarthy M. Validity of the Support Team Assessment Schedule: views of patients and families. Palliat Med. 1993;7:219-228.
43. Parmar MKB, Machin D. Survival analysis: a practical approach. Chichester: John Wiley & Sons, 1994.
44. SPSS Inc. SPSS for Windows. Base system user's guide, release 8.0. Chicago: SPSS, Inc, 1998.
45. Viganò A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861-868.
46. Perreira J, Bruera E. Chronic nausea. In: Bruera E, Higginson IJ, editors. Cachexia-anorexia in cancer patients. Oxford: Oxford University Press, 1996.
47. Bruera E, Chadwick S, MacDonald N, et al. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 1986;70:1383-1387.
48. Bruera E, Strasser F. Anorexia-cachexia. In: Bruera E, Ripamonti C, editors. Gastrointestinal symptoms in advanced cancer patients. Oxford: Oxford University Press, 2002:39-80.
49. Viganò A, Watanabe S, Bruera E. Anorexia and cachexia in advanced cancer patients. Cancer Surveys. 1994;21:99-115.
50. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage. 1991;6:360-367.
51. Ripamonti C, Bruera E. Dyspnea: pathophysiology and assessment. J Pain Symptom Manage. 1997;13:220-232.
52. Reuben DB, Mor V, Hiris J, et al. Clinical symptoms of survival in patients with terminal cancer. Arch Intern Med. 1988;148:1586-1591.
53. Bruera E, Miller MJ, Kuehn N, et al. Estimated survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992;7:82-86.
54. Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care. 1995;11:20-24.
55. Slevin MI, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988; 57:109-112.
56. Maguire P. Monitoring the quality of life in cancer patients and their relatives. In: Symington T, Williams AE, McVie JG, editors. Cancer: assessment and monitoring. London: Churchill Livingstone, 1980:40-52.
57. Viganò A, Atkinson M, Radice D, et al. Symptom assessment in terminally ill cancer patients: clinical and research insights from the Edmonton Symptom Assessment System (ESAS). Second Congress of the European Association for Palliative Care Research Network, Lyon, France, May 23-25, 2002.
58. Allison PJ, Guichard C, Fung K, Gilain L. Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer. J Clin Oncol. 2003;21:543-548.
59. Schofield P, Ball D, Smith J, Borland R, et al. Optimism and survival in lung carcinoma patients. Cancer. 2004;100:1276-1282.
60. Viganò A, Bruera E. Enteral and parenteral nutrition in cancer patients. In: Higginson I, Bruera E, editors. Cachexiaanorexia syndrome in advanced cancer. London: Oxford Medical Publications, 1996:110-127.